Literature DB >> 24915993

Interaction between Nm23 and the tumor suppressor VHL.

Chih-Hung Lin1, Vincent Dammai, Boris Adryan, Tien Hsu.   

Abstract

Among the anti-tumor genes (tumor suppressors and metastasis suppressors), the von-Hippel Lindau gene and the Nm23 family of genes are among the more intriguing ones. Both are small (long and short forms of VHL are 30 and 19 kD, respectively, and Nm23 is ~17 kD), and both possess diverse molecular and cellular functions. Despite extensive studies, the entire spectra of functions and the molecular function-phenotype correlation of these two proteins have not been completely elucidated. In this report, we present data showing these two proteins interact physically. We also summarize and confirm the previous studies that demonstrated the endocytic function of these two genes and further show that the endocytic function of VHL is mediated through the activity of Nm23. These functional and molecular interactions are evolutionarily conserved from Drosophila to human.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24915993     DOI: 10.1007/s00210-014-1002-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  53 in total

1.  LexA-based two-hybrid systems.

Authors:  S J Fashena; I G Serebriiskii; E A Golemis
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts.

Authors:  Samantha J Stehbens; Andrew D Paterson; Matthew S Crampton; Annette M Shewan; Charles Ferguson; Anna Akhmanova; Robert G Parton; Alpha S Yap
Journal:  J Cell Sci       Date:  2006-04-11       Impact factor: 5.285

3.  A critical evaluation of biochemical activities reported for the nucleoside diphosphate kinase/Nm23/Awd family proteins: opportunities and missteps in understanding their biological functions.

Authors:  Patricia S Steeg; Massimo Zollo; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-25       Impact factor: 3.000

Review 4.  Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma.

Authors:  Guru Sonpavde; Christopher D Willey; Sunil Sudarshan
Journal:  Expert Opin Investig Drugs       Date:  2014-01-03       Impact factor: 6.206

5.  nm23 protein expression in renal cell tumors: the role of the cell type.

Authors:  A Ayhan; A Usubütün; H Ozen; W Yasui; E Tahara
Journal:  Oncol Rep       Date:  1998 Jul-Aug       Impact factor: 3.906

6.  The microtubule-associated nucleoside diphosphate kinase.

Authors:  J A Nickerson; W W Wells
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

7.  Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

Authors:  Rosamonde E Banks; Prasanna Tirukonda; Claire Taylor; Nick Hornigold; Dewi Astuti; Dena Cohen; Eamonn R Maher; Anthea J Stanley; Patricia Harnden; Adrian Joyce; Margaret Knowles; Peter J Selby
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Prognostic value of nm23 protein expression in renal cell carcinomas.

Authors:  Y Nakagawa; K Tsumatani; N Kurumatani; M Cho; Y Kitahori; N Konishi; S Ozono; E Okajima; Y Hirao; Y Hiasa
Journal:  Oncology       Date:  1998 Jul-Aug       Impact factor: 2.935

10.  Receptor-mediated endocytosis of keratinocyte growth factor.

Authors:  C Marchese; P Mancini; F Belleudi; A Felici; R Gradini; T Sansolini; L Frati; M R Torrisi
Journal:  J Cell Sci       Date:  1998-12       Impact factor: 5.285

View more
  6 in total

Review 1.  Janus-faces of NME-oncoprotein interactions.

Authors:  Nikolina Vlatković; Shie-Hong Chang; Mark T Boyd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-01       Impact factor: 3.000

Review 2.  Nucleoside diphosphate kinases (NDPKs) in animal development.

Authors:  Krisztina Takács-Vellai; Tibor Vellai; Zsolt Farkas; Anil Mehta
Journal:  Cell Mol Life Sci       Date:  2014-12-24       Impact factor: 9.261

Review 3.  Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features.

Authors:  Min Fang; Yifeng Tao; Zhimin Liu; Hao Huang; Min Lao; Lingsha Huang; Bo Zhu
Journal:  Biomed Res Int       Date:  2017-03-16       Impact factor: 3.411

Review 4.  Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation.

Authors:  Bokyung Kim; Kong-Joo Lee
Journal:  Exp Mol Med       Date:  2021-03-22       Impact factor: 8.718

5.  Correlation between ultrasonic features and expression levels of C-erbB-2, VEGF and nm23 in breast cancer.

Authors:  Min Nie; Yongchun Qin; Jiafeng Zhu; Yanzhi Li; Zhibin Wang
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

6.  The Subcellular Localization and Oligomerization Preferences of NME1/NME2 upon Radiation-Induced DNA Damage.

Authors:  Martina Radić; Marko Šoštar; Igor Weber; Helena Ćetković; Neda Slade; Maja Herak Bosnar
Journal:  Int J Mol Sci       Date:  2020-03-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.